Last Close
54.58 $
Jul 2, 26
Market Cap
9.1 B $
Q1 2026 (TTM)
52-Week Range
%+88.2
%42.2
0.77
0.86
%-0.9
-%22.2
1M
+32.1%
3M
+56.7%
6M
+95.1%
YTD
+95.1%
1Y
+88.2%
3Y
+79.0%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
ALKS last closed at 54.58 $ (Jul 2, 26). Price data is refreshed after every trading day.
Alkermes Plc trades at a trailing-twelve-month P/E of 59.40. See the comparison tables on the Peers tab for the industry context.
Alkermes Plc (ALKS) has a market capitalization of approximately 9.1 B $ as of the latest reported period.
Key peers of Alkermes Plc include Laboratorios Farmaceuticos ROVI, Bausch Health Companies Inc, Merck KGaA, EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.